BEAM — Beam Therapeutics Inc

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

Trend Edge Setup Score

Trend Edge rates BEAM Bullish with a Setup Score of 7, net conviction 23, actionability 2. How the Setup Score works →

Total Setup Score7
Directional BiasBullish
Net Conviction23
Actionability2 (in range)

Key signals behind this score

About Beam Therapeutics Inc

Beam Therapeutics Inc., a biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States. Its programs in hematology and genetic disease portfolio include Ristoglogene autogetemcel, a patient-specific, autologous hematopoietic stem cell (HSC) therapy for the treatment of sickle cell disease; BEAM-302, a liver-targeting lipid nanoparticle (LNP) for the treatment of… Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$28.33
Market Cap$2.93B
Float88.2M
Shares Outstanding103.3M
Price/Sales (TTM)18.79
vs. Analyst Target+84.1% to analyst PT
Profit Margin-55.45%
Operating Margin (TTM)-25827.14%
Revenue (TTM)$156M
Dividend RateNone
Analyst Target Price$52.15 (17 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2020 $24,000 -$195M -$103M -$128M
2021 $51.8M -$371M -$180M -$230M
2022 $60.9M -$289M -$251M -$272M
2023 $378M -$133M $378M -$102M
2024 $63.5M -$377M -$304M -$355M
2025 $140M -$80.0M $117M -$29.9M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Sep 2025 $9.7M -$113M
Dec 2025 $114M $244M
Mar 2026 $31.7M -$94.3M
Jun 2026 N/A -$123M

Ownership & Float

Insider Ownership1.4%
Institutional Ownership107.9%
Short Float26.6%
% of All Funds Holding3.12%
Number of Funds Holding274

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$29.27Near-term / short-term trend
Weekly40-Week SMA$28.42Medium-term trend
Weekly80-Week SMA$24.67Cyclical trend (business cycle)
Weekly200-Week SMA$27.70Secular trend (multi-year)
Monthly10-Month SMA$28.44Near-term monthly trend
Monthly20-Month SMA$24.71Medium-term monthly trend
Monthly40-Month SMA$25.87Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$34.60 resistance 1.17x 0 months ago
$16.20 support 1.46x 10 months ago

Historical Earnings Reactions (27 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap 0.67% 0.29% 55.56% 8.65% -3.64%
1 Day 1.24% 0.63% 59.26% 11.24% -8.77%
1 Week 0.91% -2.67% 44.44% 29.73% -13.39%
2 Weeks 0.89% -1.84% 44.44% 29.56% -20.10%
1 Month 8.81% 5.45% 53.85% 122.69% -25.60%

Next earnings: October 23, 2026 (59 days away)

Seasonality & Day-of-Week Patterns

Monthly Seasonality

Insufficient historical data for monthly seasonality analysis (requires 7+ years of data).

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday 0.47% 53.4% 307
Tuesday 0.20% 48.2% 340
Wednesday 0.28% 53.0% 338
Thursday -0.09% 47.3% 330
Friday -0.08% 48.5% 328

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 107.9%

Insider Transactions — Smart Summary

Total insider ownership: 1.4%

12-Month Insider Activity Summary

Total Filings22
Net Value-$9.0M
Net Shares Change-307,765
% of Float-0.3%
C-Suite Filings20
Clusters Detected4

Key Insiders

NameTitleNet ValueFilingsActivity
FMR LLC -$10.1M 2 2 sell
Evans John M. CEO -$1.1M 1 N/A
Bellon Christine Chief Legal Officer -$791,230.138 2 N/A
Simon Amy Chief Medical Officer -$593,722.914 2 N/A
Cavanagh Bethany J SVP, Finance and Treasurer -$296,621.459 2 N/A
Ciaramella Giuseppe President -$290,289.8 1 N/A

Transaction Clusters

PeriodFilingsInsidersNet ValueSeniority
2025-10-03 – 2025-10-03 3 3 -$1.2M 3 C-suite
2026-01-20 – 2026-02-02 5 3 -$2.4M 5 C-suite
2026-04-01 – 2026-04-06 6 5 -$2.5M 6 C-suite
2026-06-29 – 2026-07-02 3 3 -$11.8M 2 C-suite

Significant Filings

DateInsiderTitleNet ValuePrice After
2026-06-29 FMR LLC -$10.0M Transaction at $35.24, now -19.6%
2026-07-29 Simon Amy Chief Medical Officer -$429,036.914 Transaction at $25.74, now +10.1%
2025-10-29 FMR LLC -$12,246.12 Transaction at $26.68, now +6.2%
2026-01-26 Cavanagh Bethany J SVP, Finance and Treasurer -$216,933.099 Transaction at $35.00, now -19.1%
2026-01-20 Bellon Christine Chief Legal Officer -$644,831.658 Transaction at $34.61, now -18.2%
2026-04-01 Evans John M. CEO -$1.1M Transaction at $11.62, now +143.8%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Beam Therapeutics Inc (BEAM) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for BEAM on Trend Edge →